RxDoctor Payments Data

Alan Job, MD

Orthopaedic Surgery of the Spine · Bronx, NYNPI 1770080475

Payments from drug & device makers

What this record shows

This record is dominated by grants: $50,000 of the $61,167 with a category attached, or 81.7%. Medtronic accounts for 83.9% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2023 at $53,470 and has fallen 93.0% since, to $3,742 in 2025.

$61,167in general payments, 2019–2025

Across 56 payments — averaging $1092.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$51K
  • Spineart USA Inc$5K
  • Stryker$3K
  • Synthes GmbH$819
  • Orthofix Medical, Inc.$233
  • Cerapedics Inc.$202
  • plus $572 from 5 others

What the payments were for

  • Grants$50,00082%
  • Travel & lodging$6,09310%
  • Food & beverage$4,6998%
  • Education$3751%

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic10$51,346
Spineart USA Inc16$5,415
Stryker19$2,581
Synthes GmbH2$819
Orthofix Medical, Inc.2$233
Cerapedics Inc.1$202
BD1$183
Si-bone, Inc.1$173
Vertex1$123
Baxter Healthcare1$48
Johnson & Johnson(2 entities)2$46

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$61,167 in reported general payments places this provider in the 70th percentile of 161 orthopaedic surgery of the spine providers in New York.

See all orthopaedic surgery of the spine providers in New York

Medicare billing

Part B allowed, 2024
$48,182
Medicare patients
94
Services billed
432

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium70$2,343
Meloxicam34$176
Methylprednisolone21$163
Gabapentin19$158
Cyclobenzaprine Hcl30$150

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Bronx

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →